Hi Anirban, Let me give a more concerned view of CRTO, and why I sold over half of my position (but certainly not ALL), to reinvest elsewhere.
Free Cash Flow in the past three quarters (Dec, Mar Jun) has gone from 30 to 17 to 11. Lest you think that’s seasonal, the year before the same three quarters went from 5 to 8 to 11. (This quarter FCF was flat with the year before at 11).
Adjusted earnings compared to the year before:
Dec - up 185%
Mar - up 133%
Jun - up 67%
Since those are percentage increases you can’t blame that on seasonality.
And speaking of seasonality, sequentially from Dec to June, adjusted earnings have fallen from 37 to 28 to 15. That’s down almost 60%. The year before the “seasonal” fall from Dec to June was just about 30%.
Adjusted EBITDA compared to the year before:
Dec - up 121%
Mar - up 93%
Jun - up 67%
Since those are percentage increases you can’t blame that on seasonality.
And speaking of seasonality, sequentially from Dec to June, adjusted EBITDA has fallen from 32 to 28 to 22. That’s down 31%. The year before the “seasonal” fall from Dec to June was only 9%.
Revenue ex-TAC compared to the year before:
Dec - up 74.5%
Mar - up 66.7%
Jun - up 64.2%
Just slowing down all over.
And speaking of seasonality, sequentially from Dec to June, Revenue ex-TAC has gained 14.6%. The year before the gain from Dec to June was 21.8%.
Now the big deal, EBITDA margins! What’s going on here with Revenue rising sequentially and adjusted Earnings and adjusted EBITDA falling sequentially?
EBITDA margin
Dec - 33.3%
Mar - 26.6%
Jun - 20.0%
That’s a major drop in the face of increasing income.
And EPS margins? We have 14.6% MORE revenue in June than December, but 60% less adjusted EPS???
This isn’t disaster by any means. They are still growing quite nicely. But those aren’t happy numbers. Just another point a view.
Saul